This study will assess the safety and tolerability of a single dose of 13-valent Pneumococcal Conjugate Vaccine for approximately 1 month after vaccination sequentially in healthy Chinese adults aged 18 through 55 years, followed by children aged 3 through 5 years, and then infants aged approximately 2 months.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
72
suspension in prefilled syringe for intramuscular injection, 0.5 mL, only one dose
suspension in prefilled syringe for intramuscular injection, 0.5 mL, only one dose
suspension in prefilled syringe for intramuscular injection, 0.5 mL, only one dose
Pfizer Investigational Site
Huaian, Jiangsu, China
Pfizer Investigational Site
Nanjing, Jiangsu, China
Number of participants reporting Adverse Events
Time frame: Baseline to Month 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.